Mike Benvenuti
Manager, Cove Fund II @ Cove Fund
Mike Benvenuti is a seed investor at Cove Fund focused on Internet and Health Care. Mike Benvenuti is the Fund Manager of Cove Fund II and a Chairman of the Board Member of OnSite Waste Technologies.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 40%
Last updated:
For AI agents: llms.txt
Industries Mike Benvenuti invests in
Stages Mike Benvenuti invests in
Countries Mike Benvenuti invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Internet 2 (40%)
- Health Care 2 (40%)
- B2B 1 (20%)
- SMS 1 (20%)
- SaaS 1 (20%)
Stage
- Seed 3 (60%)
- Series A 1 (20%)
- Series B 1 (20%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
CELITECH
|
CELITECH is an award-winning premium connectivity platform for global travel companies and their customers & employees. Our highly secure US-hosted & US-made eSIM solution delivers affordable, best-in-class cellular data service in 160+ countries. We power travel-related companies to generate new revenues and mobile engagement whilehelping their travelers save 80% on data roaming. Reach out to learn how we rock your world. | $1.2M / Seed / Aug 17, 2022 | |
Carlsmed
|
Provider of medical technology for spine surgery. The company’s proprietary aprevo™ digital-to-device 3-D printed implant system for spine is first-ever surgical implant to be designated by the FDA as a breakthrough technology. Hospital and surgeon customers across the country choose aprevo™ for the benefits of personalized medicine in lumbarfusion surgery.Carlsmed was founded in 2018 and is headquartered in San Diego, California. | $30M / Series B / Apr 19, 2022 | |
|
Carlsmed
|
Provider of medical technology for spine surgery. The company’s proprietary aprevo™ digital-to-device 3-D printed implant system for spine is first-ever surgical implant to be designated by the FDA as a breakthrough technology. Hospital and surgeon customers across the country choose aprevo™ for the benefits of personalized medicine in lumbarfusion surgery.Carlsmed was founded in 2018 and is headquartered in San Diego, California. | $10M / Series A / Dec 16, 2020 | |
|
Carlsmed
|
Provider of medical technology for spine surgery. The company’s proprietary aprevo™ digital-to-device 3-D printed implant system for spine is first-ever surgical implant to be designated by the FDA as a breakthrough technology. Hospital and surgeon customers across the country choose aprevo™ for the benefits of personalized medicine in lumbarfusion surgery.Carlsmed was founded in 2018 and is headquartered in San Diego, California. | $2.5M / Seed / Jun 23, 2020 | |
Locent
|
Locent is a digital health service focused on improving clinical document transmission for healthcare providers. Through Locent's core clinical document management service, providers improve clinical operations, ensure compliance, and simplify data exchange internally and externally. By distributing and tracking clinical documentsautomatically and on-demand, Locent saves time and lowers the administrative burden on clinicians and their assistants. | $750K / Seed / Feb 23, 2016 |
Co-Investors
About Cove Fund
Cove Fund is a seed-stage venture capital fund that provides startup funding for promising new ventures. The funds invest in early-stage technology and life science companies that demonstrate the potential to address markets with differentiated products and services, and that can achieve significant value-creating inflection points with their seedfunding.
Cove Fund Contacts
| Name | Phone | Socials | |
|---|---|---|---|
J.C. Ruffalo
Venture Partner
|
|||
|
Mike Benvenuti
Manager, Cove Fund II
|
|||
Paul Voois
Manager, Cove Fund II
|
|||
|
Fred Selby
Manager, Cove Fund I
|
|||
|
Hans Imhof
Manager, Cove Fund I
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Mike Benvenuti invest in?
Mike Benvenuti invests primarily in Internet, Health Care and B2B startups, most often at Seed and Series A stage. Most of the 5 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Mike Benvenuti?
Public channels for Mike Benvenuti include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Mike Benvenuti last invest?
The most recent investment recorded for Mike Benvenuti closed in Aug 2022. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
